181 related articles for article (PubMed ID: 27209608)
1. Enteral Access is not Required for Esophageal Cancer Patients Undergoing Neoadjuvant Therapy.
Huerter ME; Charles EJ; Downs EA; Hu Y; Lau CL; Isbell JM; McMurry TL; Kozower BD
Ann Thorac Surg; 2016 Sep; 102(3):948-954. PubMed ID: 27209608
[TBL] [Abstract][Full Text] [Related]
2. Nutritional optimization during neoadjuvant therapy prior to surgical resection of esophageal cancer-a narrative review.
Huddy JR; Huddy FMS; Markar SR; Tucker O
Dis Esophagus; 2018 Jan; 31(1):1-11. PubMed ID: 29024949
[TBL] [Abstract][Full Text] [Related]
3. Nutritional support with endoluminal stenting during neoadjuvant therapy for esophageal malignancy.
Bower M; Jones W; Vessels B; Scoggins C; Martin R
Ann Surg Oncol; 2009 Nov; 16(11):3161-8. PubMed ID: 19636630
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Enteral Access in Patients with Esophageal Squamous Cell Carcinoma Under Neoadjuvant Therapy.
Huang CH; Wang TF; Wu YF; Cheng YT; Lo SF; Hsieh TC; Peng TC
Anticancer Res; 2018 Dec; 38(12):6939-6945. PubMed ID: 30504413
[TBL] [Abstract][Full Text] [Related]
5. Self-Expanding Metal Stents Improve Swallowing and Maintain Nutrition During Neoadjuvant Therapy for Esophageal Cancer.
Smith ZL; Gonzaga JE; Haasler GB; Gore EM; Dua KS
Dig Dis Sci; 2017 Jun; 62(6):1647-1656. PubMed ID: 28391413
[TBL] [Abstract][Full Text] [Related]
6. Nutritional management during neoadjuvant therapy for esophageal cancer.
Bower MR; Martin RC
J Surg Oncol; 2009 Jul; 100(1):82-7. PubMed ID: 19373870
[TBL] [Abstract][Full Text] [Related]
7. Preoperative enteral access is not necessary prior to multimodality treatment of esophageal cancer.
Jenkins TK; Lopez AN; Sarosi GA; Ben-David K; Thomas RM
Surgery; 2018 Apr; 163(4):770-776. PubMed ID: 29198770
[TBL] [Abstract][Full Text] [Related]
8. Management of Dysphagia in Esophageal Adenocarcinoma Patients Undergoing Neoadjuvant Chemotherapy: Can Invasive Tube Feeding be Avoided?
Cools-Lartigue J; Jones D; Spicer J; Zourikian T; Rousseau M; Eckert E; Alcindor T; Vanhuyse M; Asselah J; Ferri LE
Ann Surg Oncol; 2015; 22(6):1858-65. PubMed ID: 25476030
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of self-expanding removable metal esophageal stents during neoadjuvant chemotherapy for resectable esophageal cancer.
Pellen MG; Sabri S; Razack A; Gilani SQ; Jain PK
Dis Esophagus; 2012 Jan; 25(1):48-53. PubMed ID: 21595778
[TBL] [Abstract][Full Text] [Related]
10. Self-expanding plastic esophageal stents versus jejunostomy tubes for the maintenance of nutrition during neoadjuvant chemoradiation therapy in patients with esophageal cancer: a retrospective study.
Siddiqui AA; Glynn C; Loren D; Kowalski T
Dis Esophagus; 2009; 22(3):216-22. PubMed ID: 19207544
[TBL] [Abstract][Full Text] [Related]
11. Impact of Clinical Markers of Nutritional Status and Feeding Jejunostomy Use on Outcomes in Esophageal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy.
Jain R; Shaikh T; Yee JL; Au C; Denlinger CS; Handorf E; Meyer JE; Dotan E
Nutrients; 2020 Oct; 12(10):. PubMed ID: 33080840
[TBL] [Abstract][Full Text] [Related]
12. Reassessment of the role of enteral tube feedings for patients with esophageal cancer.
Starr B; Davis S; Ayala-Peacock D; Blackstock WA; Levine EA
Am Surg; 2014 Aug; 80(8):752-8. PubMed ID: 25105392
[TBL] [Abstract][Full Text] [Related]
13. Use of esophageal stents to relieve dysphagia during neoadjuvant therapy prior to esophageal resection: a systematic review.
Ahmed O; Bolger JC; O'Neill B; Robb WB
Dis Esophagus; 2020 Jan; 33(1):. PubMed ID: 31828290
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of perioperative immunonutrition in esophageal cancer patients undergoing esophagectomy.
Kanekiyo S; Takeda S; Iida M; Nishiyama M; Kitahara M; Shindo Y; Tokumitsu Y; Tomochika S; Tsunedomi R; Suzuki N; Abe T; Yoshino S; Hazama S; Ueno T; Nagano H
Nutrition; 2019 Mar; 59():96-102. PubMed ID: 30468936
[TBL] [Abstract][Full Text] [Related]
15. Benefits of Supplemental Jejunostomy Tube Feeding During Neoadjuvant Therapy in Patients with Locally Advanced, Potentially Resectable Esophageal Cancer.
Dalton BGA; Friedant AJ; Su S; Schatz TAP; Ruth KJ; Scott WJ
J Laparoendosc Adv Surg Tech A; 2017 Dec; 27(12):1279-1283. PubMed ID: 28777676
[TBL] [Abstract][Full Text] [Related]
16. Stents in patients with esophageal cancer before chemoradiotherapy: high risk of complications and no impact on the nutritional status.
Mão-de-Ferro S; Serrano M; Ferreira S; Rosa I; Lage P; Alexandre DP; Freire J; Mirones L; Casaca R; Bettencourt A; Pereira AD
Eur J Clin Nutr; 2016 Mar; 70(3):409-10. PubMed ID: 26669568
[TBL] [Abstract][Full Text] [Related]
17. A prospective phase II evaluation of esophageal stenting for neoadjuvant therapy for esophageal cancer: optimal performance and surgical safety.
Brown RE; Abbas AE; Ellis S; Williams S; Scoggins CR; McMasters KM; Martin RC
J Am Coll Surg; 2011 Apr; 212(4):582-8; discussion 588-9. PubMed ID: 21463793
[TBL] [Abstract][Full Text] [Related]
18. Enteral Feeding Access Has an Impact on Outcomes for Patients with Esophageal Cancer Undergoing Esophagectomy: An Analysis of SEER-Medicare.
Lorimer PD; Motz BM; Watson M; Trufan SJ; Prabhu RS; Hill JS; Salo JC
Ann Surg Oncol; 2019 May; 26(5):1311-1319. PubMed ID: 30783851
[TBL] [Abstract][Full Text] [Related]
19. Effects of neoadjuvant therapy on perioperative morbidity in elderly patients undergoing esophagectomy for esophageal cancer.
Ruol A; Portale G; Castoro C; Merigliano S; Cagol M; Cavallin F; Chiarion Sileni V; Corti L; Rampado S; Costantini M; Ancona E
Ann Surg Oncol; 2007 Nov; 14(11):3243-50. PubMed ID: 17713823
[TBL] [Abstract][Full Text] [Related]
20. Effects of an immuno-enhanced diet containing antioxidants in esophageal cancer surgery following neoadjuvant therapy.
Aiko S; Kumano I; Yamanaka N; Tsujimoto H; Takahata R; Maehara T
Dis Esophagus; 2012 Feb; 25(2):137-45. PubMed ID: 21762279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
